After a bit of a slow down in the last quarter of 2012, the first quarter of 2013 is off to a better start for financing deals in the life sciences industries, according to data that CB Insights (New York) shared with Medical Device Daily this week. The firm noted nearly $300 million of deals across the life sciences, about half of which involved companies from the drug delivery, device, diagnostics, and medical facilities and services sectors.